EIN Presswire

Migraine Drugs Market Exhaustive Analysis with USD $2.190 Billion, Highest CAGR till 2025

Migraine Drugs Market

Migraine Drugs Market

Surge in awareness about migraine treatment and prevention across the globe is anticipated to significantly drive the growth of the migraine drugs market.

Migraine Drugs Market by Type (Abortive Medicine and Preventive Medicine), Route of Administration (Oral, Injection), & Distribution Channel (Hospital-based Pharmacies, Retail Pharmacies) ”

— Allied Market Research

NE WIN SIVERS DRIVE, PROVINCE: – PORTLAND, UNITED STATES, December 14, 2021 /EINPresswire.com/ — The Migraine Drugs Market was valued at $1,713 million in 2017 and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea, and even disturbed vision in some cases.

Increase in prevalence of migraine, rapid rise in female population, and surge in awareness among patients for migraine treatment & prevention drive the growth of the global migraine drugs market. However, side effects of migraine drugs are expected to limit the market growth. Conversely, emerging new therapies/drugs for migraine treatment and growth opportunities in the emerging nations are expected to present opportunities for the market growth during the forecast period.

𝗙𝗼𝗿 𝗥𝗶𝗴𝗵𝘁 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀, 𝗚𝗲𝘁 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 𝗮𝘁: https://www.alliedmarketresearch.com/request-sample/2811

By type, abortive medicines accounted for more than three-fourths share of the global migraine drugs market in 2017. Furthermore, by route of administration, the oral segment is anticipated to grow at the highest rate of 3.4% during the forecast period.

North America was the leading revenue contributor to the global market in 2017, owing to surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities.

𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗽𝗿𝗼𝗳𝗶𝗹𝗲𝘀 𝗼𝗳 𝗺𝗮𝗷𝗼𝗿 𝗺𝗮𝗿𝗸𝗲𝘁 𝗽𝗹𝗮𝘆𝗲𝗿𝘀, 𝘀𝘂𝗰𝗵 𝗮𝘀

Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc.

The other players in the value chain (not included in the report) include Novartis International AG, Teva Pharmaceutical Industries Limited, and Sanofi SA.

😷 𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗜𝗺𝗽𝗮𝗰𝘁 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝘁: https://www.alliedmarketresearch.com/request-for-customization/2811?reqfor=covid

✯ 𝗞𝗲𝘆 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗳𝗼𝗿 𝗦𝘁𝗮𝗸𝗲𝗵𝗼𝗹𝗱𝗲𝗿𝘀

✦The study provides an in-depth analysis of the Migraine Drugs Market along with the current trends and future estimations to elucidate the imminent investment pockets.

✦It offers Migraine Drugs Market analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

✦A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

✦The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Migraine Drugs Market growth.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐏𝐫𝐨𝐜𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐕𝐢𝐬𝐢𝐭 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/purchase-enquiry/2811

𝗙𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗔𝘀𝗸𝗲𝗱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀?

Q1. What are the leading market players active in Migraine Drugs Market?
Q2. What current trends will influence the market in the next few years?
Q3. What are the driving factors, restraints, and opportunities in the market?
Q4. What are the projections for the future that would help in taking further strategic steps?

𝗔𝘃𝗲𝗻𝘂𝗲 𝗕𝗮𝘀𝗶𝗰 𝗣𝗹𝗮𝗻 | 𝗟𝗶𝗯𝗿𝗮𝗿𝘆 𝗔𝗰𝗰𝗲𝘀𝘀 | 𝟭 𝗬𝗲𝗮𝗿 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

𝗧𝗿𝗲𝗻𝗱𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆:

Medical Laser Market – Global Opportunity & Industry Forecast, 2026
Minimally Invasive Surgery Market – Global Opportunity & Industry Forecast, 2030

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

vancaylahoa

Trần Xuân Quốc là một người có đam mê về thời trang, công nghệ, làm đẹp. Quốc chuyên tìm hiểu, nghiên cứu thông tin về các sản phẩm, phương pháp làm đẹp, giải pháp công nghệ để gửi đến tất cả mọi người. Các thông tin bổ ích nhất. Mong mọi người đón đọc và luôn ủng hộ quốc nhé

Related Articles

Back to top button
Close
Close